Long-Term Extension Study of Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy in Patients With K-L Grade III Knee Osteoarthritis After JOINTSTEM Administration
Latest Information Update: 30 Sep 2022
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 26 Sep 2022 Planned End Date changed from 31 Dec 2028 to 31 Dec 2029.
- 26 Sep 2022 Planned primary completion date changed from 1 Dec 2027 to 1 Dec 2028.
- 26 Sep 2022 Planned initiation date changed from 1 Dec 2021 to 1 Dec 2023.